73 related articles for article (PubMed ID: 9615819)
1. [Parameters of cellular immunity in lung cancer patients with different types of adaptation reactions during polychemotherapy].
Stakheeva MN; Dizer IA; Smol'ianinov ES; Goldberg VE; Novitskiĭ EV; Sherstoboev EIu; Khlusova MIu
Vopr Onkol; 1998; 44(2):164-6. PubMed ID: 9615819
[TBL] [Abstract][Full Text] [Related]
2. [Effect of Scutellaria baicalensis extract on the immunologic status of patients with lung cancer receiving antineoplastic chemotherapy].
Smol'ianinov ES; Gol'dberg VE; Matiash MG; Ryzhakov VM; Boldyshev DA; Litvinenko VI; Dygaĭ AM
Eksp Klin Farmakol; 1997; 60(6):49-51. PubMed ID: 9460600
[TBL] [Abstract][Full Text] [Related]
3. [The effect of antitumor chemotherapy on the lipid spectrum of the erythrocyte membranes in lung cancer patients].
Novitskiĭ VV; Stepovaia EA; Bazhenova NG; Gol'dberg VE; Kolosova MV; Saprykina EV; Sokolova IB; Koreshkova KG; Bulavina IaV
Eksp Klin Farmakol; 1999; 62(1):56-9. PubMed ID: 10198770
[TBL] [Abstract][Full Text] [Related]
4. Radio- and chemotherapy variably affect the general immunocompetence of lung cancer patients.
Vucković-Dekić L; Susnjar S; Stanojević-Bakić N; Radosavljević D
Panminerva Med; 1999 Jun; 41(2):129-33. PubMed ID: 10479911
[TBL] [Abstract][Full Text] [Related]
5. [Reversible aggregation and the surface architectonics of the peripheral blood erythrocytes in lung cancer patients before and during the carrying out of antitumor polychemotherapy].
Novitskiĭ VV; Stepovaia EA; Gol'dberg VE; Kolosova MV; Koreshkova KG; Sokolova IB; Bulavina IaV
Eksp Klin Farmakol; 1999; 62(5):28-30. PubMed ID: 10572748
[TBL] [Abstract][Full Text] [Related]
6. [Value of polychemotherapy for bronchogenic carcinoma other than undifferentiated small cell carcinoma].
Laberge F; Desmeules M; Bergeron D; La Forge J; Cormier Y
Union Med Can; 1984 Mar; 113(3):222-4. PubMed ID: 6730096
[No Abstract] [Full Text] [Related]
7. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Yamaguchi K; Fukuhara S
J Cancer Res Clin Oncol; 2002 Jan; 128(1):29-36. PubMed ID: 11862469
[TBL] [Abstract][Full Text] [Related]
8. [Cell mediated immunity in lung cancer].
Szczepaniec M
Folia Med Cracov; 1979; 21(1):49-72. PubMed ID: 396193
[No Abstract] [Full Text] [Related]
9. [Effect of systemic chemotherapy on clinical status and biological and immunologic markers in patients with breast cancer].
Orlova RV; Chernetsova LF; Matveeva ON
Vopr Onkol; 2007; 53(4):414-8. PubMed ID: 17969403
[TBL] [Abstract][Full Text] [Related]
10. Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.
Antonia SJ; Mirza N; Fricke I; Chiappori A; Thompson P; Williams N; Bepler G; Simon G; Janssen W; Lee JH; Menander K; Chada S; Gabrilovich DI
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):878-87. PubMed ID: 16467102
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic damage in lymphocytes of patients undergoing therapy for small cell lung cancer and ovarian carcinoma.
Padjas A; Lesisz D; Lankoff A; Banasik A; Lisowska H; Bakalarz R; Góźdź S; Wojcik A
Toxicol Appl Pharmacol; 2005 Dec; 209(2):183-91. PubMed ID: 15885733
[TBL] [Abstract][Full Text] [Related]
12. [Whole-brain radiotherapy combined with COAPC regimen in patients with non-small cell lung cancer].
Chen LK; Xu GC; Liu GZ; Liang Y; Liu JL; Zhou XM
Ai Zheng; 2003 Apr; 22(4):407-10. PubMed ID: 12704000
[TBL] [Abstract][Full Text] [Related]
13. [Long-term results of small cell lung cancer treated by surgery combined with postoperative chemotherapy: a report of 65 patients].
Zhang X; Sun Y; Huang J
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):137-9. PubMed ID: 10743080
[TBL] [Abstract][Full Text] [Related]
14. Combination versus alternating chemotherapy in small-cell lung cancer.
Lai SL; Perng RP
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul; 63(7):513-20. PubMed ID: 10934803
[TBL] [Abstract][Full Text] [Related]
15. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
Yuen AR; Fuks JZ; Ettinger DS; Chang AY; Ruckdeschel JC; Phan SC; Blum RH
Cancer J Sci Am; 2000; 6(1):34-9. PubMed ID: 10696737
[TBL] [Abstract][Full Text] [Related]
16. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
[TBL] [Abstract][Full Text] [Related]
17. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
[TBL] [Abstract][Full Text] [Related]
18. [The effect of chemotherapeutic drugs on free-radical oxidation of lipids in the lymph of lung cancer patients].
Sidorenko IuS; Frantsiiants EM; Tkacheva EM; Musienko NV; Kartashov SZ
Vopr Onkol; 1998; 44(3):297-9. PubMed ID: 9695775
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative growth characteristics of pulmonary metastases in cutaneous melanoma].
Mikhnin AE; Barchuk AS; Gershanovich ML; Keller IuM
Vopr Onkol; 2003; 49(6):730-3. PubMed ID: 14976917
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimens.
Ottolenghi L; Morasca L; Marsoni S; Piazza E; Soresi E; Libretti A; Garattini S
Biomedicine; 1980 Oct; 32(3):123-7. PubMed ID: 7448321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
